is glp3 retatrutide GLP-3 10mg Vial (Retatrutide) | Research Peptide GLP-3 R 30mg - Apollo

Medical weight loss intervention has been skyrocketing in recent years with many drugs on the market or in clinical trials, including incretin memetics or incretin receptor agonists such as Ozempic (semaglutide, SEMA) targeting glucagon-like peptide-1 (GLP-1) receptor (GLP1R) or dual agonist Mounjaro (tirzepatide) targeting GLP1R and glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR)

If you experience nausea after your injection, consider adjusting the timing of when you administer your dose

Many gastrointestinal side effects may decrease as treatment continues, but there is no guaranteed week when they disappear

Others notice nausea, fullness, or food aversions first

Digestive changes like mild constipation or loose stools sometimes occur but usually resolve as your body adjusts

These drugs copy a hormone which boosts insulin release, decreases glucagon, and slows the gastric emptying process